Literature DB >> 20561681

Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.

Jens Schäfer1, Sabrina Höbel, Udo Bakowsky, Achim Aigner.   

Abstract

The efficient delivery of nucleic acids into cells is critical for successful gene therapy or gene knockdown. Polyethylenimines (PEIs) are positively charged polymers which complex and deliver DNA for gene transfection or small interfering RNAs (siRNAs) for the induction of RNA interference (RNAi), and mediate their endosomal release. Likewise, various liposomes act as transfection reagents, with some lipids showing increased endocytosis and influencing endosomal escape. This study combines the favourable properties of PEI and lipid systems for DNA and siRNA delivery. Various lipids and lipid combinations, which cover a broad range of physicochemical properties and form optimal liposomes, are assessed. By addition of the liposomes to pre-formed polyplexes, based on the low molecular weight PEI F25-LMW, we establish liposome-PEI complexes (lipopolyplexes) and characterise them in comparison to their 'parent' polyplexes and liposomes regarding size, shape and zeta-potential. Furthermore, while the lipidation of polyplexes generally decreases their toxicity, our studies on DNA transfection and siRNA-mediated knockdown also establish certain lipopolyplexes based on rigid, negatively charged lipids as particularly efficient vehicles for nucleic acid delivery, further improving DNA transfection. The analysis of their mechanism and kinetics of cellular uptake confirms that the biological properties of lipopolyplexes are mainly determined by the liposome shell. We conclude that certain lipopolyplexes show improved biological properties over PEI complexes, thus representing potentially attractive non-viral vectors for gene therapy and RNAi. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20561681     DOI: 10.1016/j.biomaterials.2010.05.043

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  45 in total

Review 1.  Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors:  Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

2.  Selective Delivery of an Anticancer Drug with Aptamer-Functionalized Liposomes to Breast Cancer Cells in Vitro and in Vivo.

Authors:  Hang Xing; Li Tang; Xujuan Yang; Kevin Hwang; Wendan Wang; Qian Yin; Ngo Yin Wong; Lawrence W Dobrucki; Norio Yasui; John A Katzenellenbogen; William G Helferich; Jianjun Cheng; Yi Lu
Journal:  J Mater Chem B       Date:  2013-10-21       Impact factor: 6.331

3.  P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells.

Authors:  Gemma Navarro; Rupa R Sawant; Swati Biswas; Sean Essex; Conchita Tros de Ilarduya; Vladimir P Torchilin
Journal:  Nanomedicine (Lond)       Date:  2012-01       Impact factor: 5.307

4.  N-terminus-modified Hec1 suppresses tumour growth by interfering with kinetochore-microtubule dynamics.

Authors:  M Orticello; M Fiore; P Totta; M Desideri; M Barisic; D Passeri; J Lenzi; A Rosa; A Orlandi; H Maiato; D Del Bufalo; F Degrassi
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

5.  Recent advances in nonviral vectors for gene delivery.

Authors:  Xia Guo; Leaf Huang
Journal:  Acc Chem Res       Date:  2011-08-26       Impact factor: 22.384

6.  Trimethyl chitosan-cysteine nanoparticles for systemic delivery of TNF-α siRNA via oral and intraperitoneal routes.

Authors:  Chunbai He; Lichen Yin; Cui Tang; Chunhua Yin
Journal:  Pharm Res       Date:  2013-05-29       Impact factor: 4.200

7.  Phospholipid-polyethylenimine conjugate-based micelle-like nanoparticles for siRNA delivery.

Authors:  Gemma Navarro; Rupa R Sawant; Sean Essex; Conchita Tros de Ilarduya; Vladimir P Torchilin
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

8.  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.

Authors:  Ai-Ming Yu; Young Hee Choi; Mei-Juan Tu
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

9.  Gene delivery from supercharged coiled-coil protein and cationic lipid hybrid complex.

Authors:  Haresh T More; Joseph A Frezzo; Jisen Dai; Seiichi Yamano; Jin K Montclare
Journal:  Biomaterials       Date:  2014-05-27       Impact factor: 12.479

10.  Optimized polyethylenimine (PEI)-based nanoparticles for siRNA delivery, analyzed in vitro and in an ex vivo tumor tissue slice culture model.

Authors:  Alexander Ewe; Sabrina Höbel; Claudia Heine; Lea Merz; Sonja Kallendrusch; Ingo Bechmann; Felicitas Merz; Heike Franke; Achim Aigner
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.